Delivery Order SPE2DB22D1017-SPE2DB25FYRPW
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections (0.5 mL units). This competitively awarded, firm fixed-price delivery order carries a ceiling value of $20,677.02 and is scheduled for completion by October 17, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a $42,104.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $8,145.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. The contract, which was competitively awarded without set-aside restrictions, is scheduled for completion by August 8, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,661.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The order will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,677.45 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,062.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on September 22, 2025, with an ultimate completion date of September 23, 2025. This award was made under firm fixed-price terms with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $39,215.73 to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen injections. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price, non-set-aside procurement fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,524.66 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections on September 19, 2025, with completion scheduled for September 22, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $3,515.84 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injectors on June 18, 2025, with completion expected by June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.86 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on September 24, 2025. This contract utilizes firm fixed pricing and was competitively awarded without any set-aside designation. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance at the company's headquarters in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 25,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRPWDelivery Order
The Defense Logistics Agency awarded a $1,348 delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen injections on September 22, 2025, with completion targeted for September 23, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply agreement running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates capability in delivering brand-name and generic medications across multiple therapeutic domains, including specialty pharmaceuticals, vaccines, and medical devices. This Zepbound delivery order aligns with AmerisourceBergen's established role as a pharmaceutical prime vendor supporting Defense Health Agency and other government healthcare systems through flexible, competitively awarded contract vehicles designed to ensure reliable medical supply availability for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/22/25 |